Diabetes in Mayan Populations: Monitoring of Glycosylated Hemoglobin
Ethnicity & Disease · 01.05.2025 · 35 (2) · 65-72
DOI: 10.18865/ethndis-2023-65 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ethnicity & Disease, online erschienen am 07.05.2025. Verfasst von Karla Stephanie Vázquez Encalada und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemical Engineering, Universidad Autónoma de Yucatán, Mérida, Yucatán, México. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Diabetes Mellitus. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetes mellitus (DM) is a global health concern that has affected various populations worldwide. Among the various methods to monitor the progress and management of DM, glycosylated hemoglobin (HbA1c) serves as a key marker for understanding long-term glucose control. The Mayan populations of Yucatan represent a unique demographic in which the prevalence and management of DM can be distinctively analyzed.
Method
In this study, HbA1c levels were monitored over 12 months in 1722 patients with DM from 17 medical units of the Mexican Institute of Social Security in the southern region of Yucatan. Based on initial HbA1c levels, patients were assigned to either standard or intensive treatment. Treatment efficacy was analyzed based on sex, age, and location.
Results
HbA1c levels significantly decreased in patients receiving intensive treatment, from means (±SD) of 9.7±1.9% to 8.9±2.0% after 12 months (P=.001), with notable reductions in remote areas such as Akil and Huntochac (P<.05). Although slight reductions were observed among women and middle-aged individuals, these reductions were not statistically significant (P=.2 and P=.4, respectively). Despite the initial improvement, standard treatment was more effective for maintaining long-term glycemic stability, with lower variability and better adherence. However, a 10% increase in HbA1c was observed in this group by the end of the study.
Conclusion
Monitoring of DM in Mayan populations revealed significant HbA1c reductions with intensive treatment, especially in remote areas. Consequently, strategies to improve primary care and promote self-care in DM patients in the Mayan population must be implemented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chemical Engineering, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
- Mexican Institute of Social Security, IMSS, Mérida, Yucatán, Mexico.
- Faculty of Medicine, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico.
ORCID-Profile: Maira Rubi Segura Campos
Zitieren
APA
Vázquez Encalada, K. S., Vázquez Gamboa, C. E., Martínez Rivera, J. I., Uuh Narvaez, J. J., & Segura Campos, M. R. (2025). Diabetes in Mayan Populations: Monitoring of Glycosylated Hemoglobin. Ethnicity & Disease, 35(2), 65-72. https://doi.org/10.18865/ethndis-2023-65
Vancouver
Vázquez Encalada KS, Vázquez Gamboa CE, Martínez Rivera JI, Uuh Narvaez JJ, Segura Campos MR. Diabetes in Mayan Populations: Monitoring of Glycosylated Hemoglobin. Ethnicity & Disease. 2025;35(2):65-72. doi:10.18865/ethndis-2023-65
BibTeX
@article{VzquezEncalada2025,
author = {Vázquez Encalada, Karla Stephanie and Vázquez Gamboa, Carlos Esteban and Martínez Rivera, José Iván and Uuh Narvaez, Jonatan Jafet and Segura Campos, Maira Rubi},
title = {Diabetes in Mayan Populations: Monitoring of Glycosylated Hemoglobin},
journal = {Ethnicity & Disease},
year = {2025},
volume = {35},
number = {2},
pages = {65--72},
doi = {10.18865/ethndis-2023-65}
}
EUVIMED